Evaluation of Improvement in Skin and Nail Psoriasis in Bio‐naïve Patients With Active Psoriatic Arthritis Treated With Golimumab: Results Through Week 52 of the GO‐VIBRANT Study

Evaluation of Improvement in Skin and Nail Psoriasis in Bio‐naïve Patients With Active Psoriatic Arthritis Treated With Golimumab: Results Through Week 52 of the GO‐VIBRANT Study

Objective To evaluate whether intravenous (IV) golimumab produces improvements in skin and nail symptoms that are concomitant with improvements in quality of life (QoL) and joint symptoms in patients with psoriatic arthritis. Methods Patients were randomized to either IV golimumab 2 mg/kg at weeks 0...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Philip Mease, M. Elaine Husni, Soumya D. Chakravarty, Shelly Kafka, Dennis Parenti, Lilianne Kim, Kim Hung Lo, Elizabeth C. Hsia, Arthur Kavanaugh
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Wiley 2020-11-01
Seri Bilgileri:ACR Open Rheumatology
Konular:
DLQI
intravenous golimumab
mNAPSI
psoriasis
psoriatic arthritis
Online Erişim:https://doi.org/10.1002/acr2.11180

Internet

https://doi.org/10.1002/acr2.11180

Benzer Materyaller